![Philippe Pronost](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Philippe Pronost
Private Equity Investor bij Apicap SAS
Profiel
Philippe Pronost is currently the Managing Director at Apicap SAS since 2019.
Prior to this, he worked as a Director at Laboratoire Français du Fractionnement et des Biotechnologies and La Française des Jeux SA.
Actieve functies van Philippe Pronost
Bedrijven | Functie | Begin |
---|---|---|
Apicap SAS
![]() Apicap SAS Investment ManagersFinance Apicap SAS is a Venture Capital firm, a subsidiary of OTC Holding SAS founded in 2001. Apicap SAS is headquartered in Paris. | Private Equity Investor | 19-09-2019 |
Eerdere bekende functies van Philippe Pronost
Bedrijven | Functie | Einde |
---|---|---|
LA FRANÇAISE DES JEUX | Directeur/Bestuurslid | - |
Laboratoire Français du Fractionnement et des Biotechnologies
![]() Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
LA FRANÇAISE DES JEUX | Consumer Services |
Bedrijven in privébezit | 2 |
---|---|
Laboratoire Français du Fractionnement et des Biotechnologies
![]() Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | Health Technology |
Apicap SAS
![]() Apicap SAS Investment ManagersFinance Apicap SAS is a Venture Capital firm, a subsidiary of OTC Holding SAS founded in 2001. Apicap SAS is headquartered in Paris. | Finance |